Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.84

+1.8%

Dec 19 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1459)	8/24/2000 6:15:00 PM
From: Elmer	Read Replies (3) of 52153

Peter, you and Richard are the most astute biotech investors on SI. Can you help me with a question? Dendreon has an open blind Phase II trial for a cancer drug called Mylovenge. The preliminary Phase II results appear to be outstanding. See Message 14269311 Generally is there any strong correlation between early results and final Phase III results? Thanks

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next